OR WAIT null SECS
Recipharm has invested EUR 32 million ($43 million) in its Wasserburg, Germany site to expand lyophilization capacity.
Recipharm will invest EUR 32 million ($43 million) in its Wasserburg, Germany site located near Munich to create a new building that will house a fourth production area adding to the three already in operation. This development will increase the company’s lyophilization capacity and automatic loading and unloading technology. The building will also have the flexibility to accommodate further production lines. The number of employees will be increased from the current 282 to 320, and the new area is expected to be operational in 2016.